Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
Depreciation & Amortization
Fuji Pharma Co Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fuji Pharma Co Ltd
TSE:4554
|
Depreciation & Amortization
¥3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Depreciation & Amortization
¥728B
|
CAGR 3-Years
9%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Depreciation & Amortization
¥59.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Depreciation & Amortization
¥101B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Depreciation & Amortization
¥31.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Astellas Pharma Inc
TSE:4503
|
Depreciation & Amortization
¥157.8B
|
CAGR 3-Years
30%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
See Also
What is Fuji Pharma Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
3B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Depreciation & Amortization amounts to 3B JPY.
What is Fuji Pharma Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
8%
Over the last year, the Depreciation & Amortization growth was 10%. The average annual Depreciation & Amortization growth rates for Fuji Pharma Co Ltd have been 14% over the past three years , 6% over the past five years , and 8% over the past ten years .